The ethical questions surrounding the recruitment of patients for clinical trials become more complicated when the recruiting physicians receive financial benefits for each patient enrolled.

Murray Kopelow, chief executive of the Accreditation Council for Continuing Medical Education, discusses his organization's the new draft standards for commercial support of continuing medical education.

Legal and ethical questions arise when a physician receives remuneration for prescribing a drug to a patient.

The AMA's Code of Medical Ethics provides ample guidance for the interactions between pharmaceutical companies and physicians.

An overview of new guidelines for preventing and managing hypertension.

The financial generosity of the pharmaceutical industry to provide funding for medical education tempts a compromise of professional standards and ethics.

In April 2002, many pharmaceutical companies adopted PhRMA code, an attempt to self-regulate the pharmaceutical industry's marketing to physicians and other health care professionals.

Physicians should encourage pharmaceutical companies to make socially responsible funding decisions and take an active role in setting biomedical research priorities by advocating for fair and effective allocations of public and private biomedical R & D investments.

A spoof on the Twelve Days of Christmas about the various gifts to physicians from industry.

A Canadian physician reports there is systematic bias to the outcome of published research funded by the pharmaceutical industry and believes more steps need to be taken to improve the integrity of clinical research reports in the United States and Canada.